Expression, clinical significance and biological function of CDC7 in osteosarcoma

Objective To investigate the expression and clinical significance of cell division cycle 7 (CDC7) in osteosarcoma (OS) and its effect on the proliferation, migration and invasion of OS cells. Methods The mRNA microarray data from the Gene Expression Omnibus (GEO) database was used to analyze the exp...

Full description

Saved in:
Bibliographic Details
Main Authors: CHEN Peijun, MAN Yunan, HE Mingwei, LIANG Bumin, HE Maolin
Format: Article
Language:zho
Published: Editorial Office of Journal of Guangxi Medical University 2025-02-01
Series:Guangxi Yike Daxue xuebao
Subjects:
Online Access:https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2025.01.008
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850033906996215808
author CHEN Peijun
MAN Yunan
HE Mingwei
LIANG Bumin
HE Maolin
author_facet CHEN Peijun
MAN Yunan
HE Mingwei
LIANG Bumin
HE Maolin
author_sort CHEN Peijun
collection DOAJ
description Objective To investigate the expression and clinical significance of cell division cycle 7 (CDC7) in osteosarcoma (OS) and its effect on the proliferation, migration and invasion of OS cells. Methods The mRNA microarray data from the Gene Expression Omnibus (GEO) database was used to analyze the expression of CDC7 in OS tissues. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to verify the expression of CDC7 mRNA in human osteoblast cell line (hFOB1.19) and OS cell lines (HOS, U-2 OS, MG63). Immunohistochemistry (IHC) was used to detect the expression of CDC7 protein in 39 cases of OS tissues and 8 cases of adjacent normal tissues. The summary receiver operating characteristic (SROC) curve was employed to evaluate the diagnostic efficacy of CDC7 in OS. Kaplan-Meier survival curves were plotted to analyze the impact of CDC7 expression on the prognosis of OS patients. Univariate and multivariate Cox proportional hazards regression models were utilized to analyze risk factors for poor prognosis in OS. CDC7 small interfering RNA (si-CDC7) was used to transfect HOS cells, and cell proliferation was assessed using cell counting kit-8 (CCK-8) and EdU assays, while cell migration and invasion were evaluated using Transwell assays. Results Multiple GEO datasets indicated that CDC7 expression was up-regulated in OS (P < 0.05). Compared with hFOB1.19 cells, CDC7 mRNA expression was increased in HOS, U-2 OS and MG63 cells (P < 0.05). CDC7 protein was highly expressed in OS tissues compared with normal tissues (P < 0.001). CDC7 demonstrated good diagnostic potential for OS (AUC=0.73, 95% CI: 0.69-0.77). Patients with high CDC7 expression had a significant lower survival rate than those with low CDC7 expression (P=0.028). High CDC7 expression was an independent risk factor for poor prognosis in OS (HR=2.471, 95% CI: 1.056-5.781, P=0.037). Silencing CDC7 significantly inhibited the proliferation, migration and invasion of HOS cells. Conclusion The expression of CDC7 is upregulated in OS, and it promotes the proliferation, migration and invasion of OS cells, which is expected to be a molecular marker for the diagnosis and prognosis of OS.
format Article
id doaj-art-b98540a5d40c447b898e2afd44e6b26c
institution DOAJ
issn 1005-930X
language zho
publishDate 2025-02-01
publisher Editorial Office of Journal of Guangxi Medical University
record_format Article
series Guangxi Yike Daxue xuebao
spelling doaj-art-b98540a5d40c447b898e2afd44e6b26c2025-08-20T02:58:00ZzhoEditorial Office of Journal of Guangxi Medical UniversityGuangxi Yike Daxue xuebao1005-930X2025-02-01421566410.16190/j.cnki.45-1211/r.2025.01.008gxykdxxb-42-1-56Expression, clinical significance and biological function of CDC7 in osteosarcomaCHEN Peijun0MAN Yunan1HE Mingwei2LIANG Bumin3HE Maolin4Department of Spine and Osteopathy, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, ChinaDepartment of Spine and Osteopathy, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, ChinaDepartment of Trauma Orthopedic and Hand Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, ChinaInternational Education School of Guangxi Medical University, Nanning 530021, ChinaDepartment of Spine and Osteopathy, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, ChinaObjective To investigate the expression and clinical significance of cell division cycle 7 (CDC7) in osteosarcoma (OS) and its effect on the proliferation, migration and invasion of OS cells. Methods The mRNA microarray data from the Gene Expression Omnibus (GEO) database was used to analyze the expression of CDC7 in OS tissues. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to verify the expression of CDC7 mRNA in human osteoblast cell line (hFOB1.19) and OS cell lines (HOS, U-2 OS, MG63). Immunohistochemistry (IHC) was used to detect the expression of CDC7 protein in 39 cases of OS tissues and 8 cases of adjacent normal tissues. The summary receiver operating characteristic (SROC) curve was employed to evaluate the diagnostic efficacy of CDC7 in OS. Kaplan-Meier survival curves were plotted to analyze the impact of CDC7 expression on the prognosis of OS patients. Univariate and multivariate Cox proportional hazards regression models were utilized to analyze risk factors for poor prognosis in OS. CDC7 small interfering RNA (si-CDC7) was used to transfect HOS cells, and cell proliferation was assessed using cell counting kit-8 (CCK-8) and EdU assays, while cell migration and invasion were evaluated using Transwell assays. Results Multiple GEO datasets indicated that CDC7 expression was up-regulated in OS (P < 0.05). Compared with hFOB1.19 cells, CDC7 mRNA expression was increased in HOS, U-2 OS and MG63 cells (P < 0.05). CDC7 protein was highly expressed in OS tissues compared with normal tissues (P < 0.001). CDC7 demonstrated good diagnostic potential for OS (AUC=0.73, 95% CI: 0.69-0.77). Patients with high CDC7 expression had a significant lower survival rate than those with low CDC7 expression (P=0.028). High CDC7 expression was an independent risk factor for poor prognosis in OS (HR=2.471, 95% CI: 1.056-5.781, P=0.037). Silencing CDC7 significantly inhibited the proliferation, migration and invasion of HOS cells. Conclusion The expression of CDC7 is upregulated in OS, and it promotes the proliferation, migration and invasion of OS cells, which is expected to be a molecular marker for the diagnosis and prognosis of OS.https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2025.01.008osteosarcomacell division cycle 7molecular markerproliferationmigrationinvasion
spellingShingle CHEN Peijun
MAN Yunan
HE Mingwei
LIANG Bumin
HE Maolin
Expression, clinical significance and biological function of CDC7 in osteosarcoma
Guangxi Yike Daxue xuebao
osteosarcoma
cell division cycle 7
molecular marker
proliferation
migration
invasion
title Expression, clinical significance and biological function of CDC7 in osteosarcoma
title_full Expression, clinical significance and biological function of CDC7 in osteosarcoma
title_fullStr Expression, clinical significance and biological function of CDC7 in osteosarcoma
title_full_unstemmed Expression, clinical significance and biological function of CDC7 in osteosarcoma
title_short Expression, clinical significance and biological function of CDC7 in osteosarcoma
title_sort expression clinical significance and biological function of cdc7 in osteosarcoma
topic osteosarcoma
cell division cycle 7
molecular marker
proliferation
migration
invasion
url https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2025.01.008
work_keys_str_mv AT chenpeijun expressionclinicalsignificanceandbiologicalfunctionofcdc7inosteosarcoma
AT manyunan expressionclinicalsignificanceandbiologicalfunctionofcdc7inosteosarcoma
AT hemingwei expressionclinicalsignificanceandbiologicalfunctionofcdc7inosteosarcoma
AT liangbumin expressionclinicalsignificanceandbiologicalfunctionofcdc7inosteosarcoma
AT hemaolin expressionclinicalsignificanceandbiologicalfunctionofcdc7inosteosarcoma